Chronic administration of antipanic drugs alters rat brainstem GABA(A) receptor subunit mRNA levels

Neuropharmacology

Volumn 35, Issue 9-10, 1996, Pages 1475-1482

  Tanay, V A M I ^a   Glencorse, T A ^a,b   Greenshaw, A J ^a   Baker, G B ^a   Bateson, A N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antidepressants; GABA(A) receptors; Gene expression; Panic disorder; Subunit

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIPANIC AGENT; ANXIOLYTIC AGENT; BUSPIRONE; IMIPRAMINE; MESSENGER RNA; PHENELZINE; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DEPRESSION; DRUG TISSUE LEVEL; GABAERGIC TRANSMISSION; GENE EXPRESSION; LONG TERM EXPOSURE; MALE; NONHUMAN; OSMOTIC MINIPUMP; PANIC; PRIORITY JOURNAL; RAT; STEADY STATE;

ANIMALS; ANTI-ANXIETY AGENTS; BRAIN STEM; BUSPIRONE; GABA AGONISTS; IMIPRAMINE; MONOAMINE OXIDASE INHIBITORS; NEUROTRANSMITTER UPTAKE INHIBITORS; PANIC DISORDER; PHENELZINE; RATS; RECEPTORS, GABA-A; RNA, MESSENGER;

EID: 0030471146     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(96)00065-2     Document Type: Article

References (40)

1. Arnot M.I., Bateson A.N., Martin I.L. Dimethyl sulfoxide/propylene glycol is a suitable solvent for the delivery of diazepam from osmotic minipumps. J. Pharmacol. Toxicol. Meth. 36:1996;29-31.
2. Baker G.B., Wong J.T.F., Yeung J., Coutts R.T. Effects of the antidepressant phenelzine on brain levels of γ-aminobutyric acid. J. Affect. Dis. 21:1991;207-211.
3. A receptor α1-subunit gene promoter. Gene. 153:1995;243-247.
4. Charney D.S., Woods S.W., Price L.H., Goodman W.K., Glazer W.M. and Heninger G.R. (1990) Noradrenergic dysregulation in panic disorder. In Neurobiology of Panic Disorder (Ballenger J.C., Ed.), pp. 91-105. Willey-Liss Inc., New York.
5. Drebit R., Baker G.B., Dewhurst W.G. Determination of maprotiline and desmethylimipramine in plasma and urine by gas chromatography with nitrogen-phosphorus detection. J. Chromatogr. 432:1988;334-339.
6. A receptor. In International Review of Neurobiology (Bradley R.J. and Harris R.A., Eds), Vol. 36, pp. 51-96. Academic Press, Florida.
7. A receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites. Mol. Pharmacol. 44:1993;191-197.
8. Fyer A.J. and Sandberg D. (1988) Pharmacologic treatment of panic disorder. In Review of Psychiatry (Frances A.J. and Hales R.E., Eds), Vol. 7, pp. 88-120. American Psychiatric Press, Inc., Washington, DC.
9. Gallager D.W., Lakoski J.M., Gonsalves S.F., Rauch S.L. Chronic benzodiazepine treatment decreases post-synaptic GABA sensitivity. Nature. 308:1984;74-77.
10. Harrison N.L., Kugler J.L., Jones M.W., Greenblatt E.P., Pritchett D.B. Positive modulation of human γ-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane. Mol. Pharmacol. 44:1993;628-632.
11. A subunit mRNA in rat brain. J. Mol. Neurosci. 2:1990;101-107.
12. A receptor subunit mRNA concentrations following chronic lorazepam administration. Br. J. Pharmacol. 103:1991;1285-1287.
13. A receptors. Neuron. 3:1989;745-753.
14. A receptor mRNAs and increases ligand binding. J. Neurochem. 62:1993;2334-2337.
15. Korf J., Venema K. Desmethylimipramine enhances the release of endogenous GABA and other neurotransmitter amino acids from the rat thalamus. J. Neurochem. 40:1983;946-950.
16. Kreuger K.E. and Papadopoulos V. (1991) The peripheral-type benzodiazepine receptor: cell biological role and pharmacological significance. In Transmitter Amino Acid Receptors: Structures, Transduction and Models for Drug Development (Barnard E.A. and Costa E., Eds), Fidia Research Foundation Symposium Series, Vol. 6, pp 153-166. Thieme Medical Publishers, Inc., New York.
17. Lyles G.A., Callingham B.A. In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidase in rat cardiovascular tissues. Biochem. Pharmacol. 31:1987;1417-1424.
18. A receptor α2 and α3 subunit mRNAs as well as polypeptide expression in primary cultured cerebral cortical neurons. Mol. Brain Res. 24:1994;159-165.
19. Moody E.J., Skolnick P. The imidazobenzodiazepine Ro 15-4513 antagonizes methoxyflurane anesthesia. Life Sci. 43:1988;1269-1276.
20. Nalepa I., Vetulani J. Different mechanisms of β-adrenoceptor down-regulation by chronic imipramine and electroconvulsive treatment: possible role for protein kinase C. J. Neurochem. 57:1991;904-910.
21. Nudel U., Zakut R., Shani M., Neuman S., Levy Z., Yaffe D. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucl. Acid Res. 11:1983;1759-1771.
22. O'Donovan M.C., Buckland P.R., McGuffin P. Simultaneous quantification of several mRNA species by solution hybridization with oligonucleotides. Nucl. Acids Res. 19:1991;3466.
23. A receptor subunit mRNA in rat brain following flurazepam treatment. J. Psychopharmacol. 6:1992;364-369.
24. A receptor α subunits, after flurazepam treatment. Eur. J. Pharmacol. 226:1992;335-341.
25. A receptor α1-subunit gene. Can. J. Physiol. Pharmacol. 72(P7.1.7):1994;245.
26. Papp L.A., Klein D.F., Gorman J.M. Carbon dioxide hypersensitivity, hyperventilation and panic disorder. Am. J. Psychiatr. 150:1993;1149-1157.
27. Prasad A., Reynolds J.N. Uncoupling of GABA-benzodiazepine receptors in chick cerebral cortical neurons requires co-activation of both receptor sites. Brain Res. 591:1992;327-331.
28. A receptor subunit mRNA levels are differentially influenced by chronic FG7142 and diazepam exposure. Eur. J. Pharmacol. 226:1992;21-28.
29. Roca D.J., Rozenberg I., Farrant M., Farb D.H. Chronic agonist exposure induces down-regulation and allosteric uncoupling of the γ-aminobutyric acid/benzodiazepine receptor complex. Mol. Pharmacol. 37:1990;37-43.
30. Schwaninger M., Schofl C., Blume R., Rossig L., Knepel W. Inhibition by antidepressant drugs of cyclic-AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol. 47:1995;1112-1118.
31. Sheehan D.V., Raj A.B., Harnett-Sheehan K., Soto S., Knapp E. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study. Acta Psychiatr. Scand. 88:1993;1-11.
32. A receptor subunits exist in distinct neuronal subpopulations. Neuron. 3:1989;327-337.
33. A receptor subtypes. Pharmacol. Rev. 47:1995;181-234.
34. A receptor subunit gene expression in rat brain. Br. J. Pharmacol. 117:1996;15P.
35. Tunnicliff G. Molecular basis of buspirone's anxiolytic action. Pharmacol. Toxicol. 69:1991;149-156.
36. Weissman M.M., Wickramaratne R., Adams P.B., Lish J.D., Horwath E., Charney D., Woods S.E., Leeman E., Frosch E. Relationship between panic disorder and major depression. Arch. Gen. Psychiatr. 50:1993;767-780.
37. Weizman R., Burgin R., Gavish M. Modulatory effect of antidepressants on peripheral-type benzodiazepine receptors. Eur. J. Pharmacol. 250:1993;289-294.
38. Wong J.T.F., Baker G.B., Coutts R.T. A rapid, sensitive assay for γ-aminobutyric acid in brain using electron-capture gas chromatography. Res. Commum. Chem. Path. Pharmacol. 70:1990;115-124.
39. A receptor β subunit heterogeneity: functional expression of cloned cDNAs. EMBO J. 8:1989;1665-1670.
40. Yu R., Ticku M.K. Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons. Mol. Pharmacol. 47:1995;603-610.